India’s healthcare sector is undergoing a transformative shift, especially with the growing adoption of Internet of Medical Things (IoMT) and Digital Therapeutics (DTx). These technologies
Ahmedabad: Gujarat has further cemented its position as India’s pharmaceutical powerhouse with the state’s Food and Drug Control Administration (FDCA) approving 183 new allopathic drug
Morepen Laboratories Ltd. has got clearance from Subject Expert Committee (‘SEC’) of Central Drugs Standard Control Organization (CDSCO) to conduct Bioequivalence (‘BE’) studies for Resmetirom
Apollo Cancer Centre, Bengaluru, has launched ColFit, a comprehensive screening programme designed to detect and prevent colorectal cancer at an early stage. This initiative aims
Indian pharma researchers are now focusing on monoclonal antibodies to treat malaria. The current research is exploring new antimalarial drugs and strategies, including monoclonal antibodies,
With a mix of government backing, private investment and a strengthening academic ecosystem, the stem cell sector in the county is gaining momentum.According to Dr
In a landmark advancement for global oncology, a multi-institutional research team led by Prof Dr Raj Nagarkar, managing director and chief of surgical oncology &
Vgenomics, a leading precision health company, and Meril Genomics, a trusted diagnostics and molecular biology provider, have announced a groundbreaking partnership aimed at providing complementary
Neurologists in the country underscore the need for advanced research to better understand Parkinson’s Disease, improve therapies, and develop more effective treatments. India accounts for
The Indian pharmaceutical industry is in the midst of a green revolution with usage of solar panels and energy-efficient machinery. A new era of innovation